All News

Breast cancer and melanoma survivor finds herself waiting for results again.

A new toolkit developed by the Society for Gynecologic Oncology is aimed at increasing awareness about genetic testing for gynecologic cancers.

CURE spoke with expert Jason Luke about updates and future prospects for immunotherapy in melanoma.

Updated trial data shows that Opdivo had a high objective response rate for a cohort of patients with classical Hodgkin Lymphoma.

Vitamin D plays an important role in helping fight breast cancer.

The party is over. Now what?

Mache Seibel discusses the benefits of taking estrogen supplements for women who harbor the BRCA genetic mutation.

Androgen deprivation therapy may be linked to dementia in men with prostate cancer, according to a recent study.

Do I want to be asked how I am doing? A six year breast cancer and three-year melanoma survivor ponders this question.

There's a heartbreaking reality of making a profession out of cancer, but I chose it anyway.

The FDA approved Keytruda to treat metastatic non-small cell lung cancer in the frontline setting.

A recent study showed that caregivers of patients with high-grade gliomas experience a great amount of time burden, even in the earlier stages of diagnosis.

Three treatment options for localized prostate cancer all showed a similar low prostate-specific mortality rate.

Research in preventing that tingling and numbness in feet and hands is progressing slowly, but what can those of us already living with it do?

By mitigating some of the financial burdens, The Leukemia & Lymphoma Society helps patients better stick to treatment regimens.

Cancer can change the relationships that we have.

If you do not practice self-care, you won't be able to care for the one you love.

A Lartruvo (olaratumab) combination received an accelerated approval from the FDA to treat patients with soft tissue sarcoma.

A new tool that grades financial toxicity similar to adverse events may help patients deal with finances during cancer.

A two-time cancer survivor shares her experiences with cancer's side effects.

Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer.

The Beat AML trial just launched, and researchers are hoping it will find better treatment for patients with acute myeloid leukemia.

A trial testing Zytiga's effectiveness in ovarian cancer was recently halted.

Healing from breast cancer is difficult, but sometimes the changes are worthwhile.

LaTour clearly remembers the day of her diagnosis three decades ago.

The three winners of an international competition were awarded grant money to further develop their innovations to better the lives of patients with cancer.

A computer simulation tool may help plan treatment for certain patients with recurrent glioblastoma.

Recovery is an up-and-down process, and it's okay to show yourself compassion through the ups and the downs.